AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Natalizumab in South Africa
1 product registered with SAHPRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TYSABRI | 42/30.1/0765 | ACINO PHARMA (PTY) LTD | active | 1 Jan 1900 |
Natalizumab — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Natalizumab, of which 1 is currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Natalizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.